Directors CVs

YARIV ALROY

Yariv served in shl Telemedicine's Co-CEO from 2000 until January 15,2016. He previously served as managing director of SHL Telemedicine International Ltd from 1997 to 2000 and Chief Operating Officer of the Company from 1993 to 1997. He also previously served as a Member of the Board of Directors of the Company between 2001 and 2006, and between 2010 and 2014. Before joining the Company, Yariv worked for a leading Israeli law firm from 1989 to 1993,with my last position being senior partner. Since 2016 He as been an investor and a businessman and serves as a Board Member of Duke Robotics Inc., a private reporting US corporation. He hold an LL.B from Tel Aviv University

DAVID SALTON

Mr. Salton joined the Board of Directors avid Salton as independent, non- executive director effective as of 31 May 2021. David currently holds the position of Chief Executive Officer of Virility Medical, a startup company developing consumer medical devices. Prior to that, he served as CEO of DCL Technologies Ltd., an investment company, and Deputy General Manager of Leumi Partners, a leading Israeli Investment Bank. David Salton also served as CEO of several private biotech and healthcare companies, and as board member of several publicly traded companies. He currently is an independent director of InterCure Ltd. (TASE, TSX: INCR) and ARAN Ltd. (TASE: ARAN). David Salton holds a B.Sc., Economics & Management degree from Technion - Israel Institute of Technology, Faculty of Industrial Engineering & Management. Nationality: Israeli.

PROF. AMIR LERMAN

Prof. Lerman joined the Board of Directors of SHL as a non-executive Director in 2016. Prof. Lerman is the Vice-Chair, Cardiovascular Department and the Director of the Cardiovascular Research Center at the Mayo Clinic in Rochester (USA) since 2010. He is also the Program Director for vascular and valve, Center for Regenerative Medicine at the Mayo Clinic, since 2012. In addition, Prof. Lerman serves as the Director of the Mayo-Israeli startup company initiative as well as a faculty member at the Mirage Institute: US-Israel innovation bridge business leadership program, since 2009, in addition to various other positions held at the Mayo Clinic. Prof. Lerman also holds an appointment as Professor of Medicine at the Mayo Medical School since 2001. Prof. Lerman graduated from the Technion school of Medicine in Haifa Israel in 1985 and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic in 1994. Prof. Lerman published more than 500 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research. Nationality: American/ Israeli.

EREZ NACHTOMY

Mr. Erez Nachtomy serves as a member of the Board since December 2018 and as Acting CEO of the company as of May 2020. From 1989 until 2001 Erez practiced law at a leading Israeli law firm - Weksler, Bregman

• Co., becoming a partner in the firm in 1994 and later on promoted to a senior partner. In March 2001, He joined the executive team of SHL Telemedicine Ltd., as Vice President, and from January 2005 to December 2016 He served as Executive Vice President of the Company. Since 2017 he is an investor and a businessman specializing in strategic planning, M&A transactions, and capital raising and business development. He serves as a Board Member of Duke Robotics, Inc., a private reporting US corporation. Erez hold an LL.B. from Tel Aviv University, Israel and he is a member of the Israeli Bar.
  Nationality: Israeli.

EREZ ALROY

Mr. Alroy served in various executive positions in SHL Telemedicine since its inception, as its Co-CEO from 2000 to January 2015 and as a director from 2008 to 2014.He is currently active in various investments and is a board member in Merhavia Holdings Ltd (TASE:MRHL) and is the Chairman of Migvan Engineering and Technology Ltd.Mr. Alroy holds an MBA from the Hebrew University in Jerusalem. Nationality: Israeli.